How to appeal a Blue Cross NC liver (non-hcv) — nash/mash, pbc, aih, wilson denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross NC-specific note: BCBS licensee for North Carolina (~4.3M members). Prime Therapeutics PBM. NC DOI oversight. Blue Premier is the high-profile value-based care program. Recently divested some Medicaid business; Healthy Blue (joint venture with Elevance) handles NC Medicaid.

What Blue Cross NC's policy requires for liver (non-hcv) — nash/mash, pbc, aih, wilson

Cited policy: BCBS Specialty Pharmacy — IBAT inhibitors (Bylvay, Livmarli) for PFIC / Alagille

PFIC (Bylvay >=3 mo) or Alagille (Livmarli >=1 yr) genotype-confirmed. Pediatric hepatologist Rx.

How Blue Cross NC denies liver (non-hcv) — nash/mash, pbc, aih, wilson — and how to counter it

Where Blue Cross NC pushes back: 1) 'Pediatric/rare — needs specialist'; 2) Cost-prohibitive; 3) Off-label use.

Counter-arguments that hold up: Both FDA-approved for pediatric cholestatic pruritus (Bylvay Jul 2021 PFIC, Jun 2023 Alagille; Livmarli Sep 2021 Alagille, Mar 2024 PFIC). PEDFIC-1/2 + MARCH pivotal. Specialist letter from pediatric hepatologist. Orphan drug designation; no alternative IBAT inhibitor.

What Blue Cross NC typically denies for liver (non-hcv) — nash/mash, pbc, aih, wilson

Across Blue Cross NC's commercial and Medicare books, denials cluster around a small number of patterns. For liver (non-hcv) — nash/mash, pbc, aih, wilson, expect:

• Step therapy via Prime Therapeutics
• Blue Premier value-based arrangement disputes
• Out-of-network reductions
• Specialty drug PA

Treatments most often denied in this category

These are the liver (non-hcv) — nash/mash, pbc, aih, wilson treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Rezdiffra (NASH)
• Ocaliva
• Iqirvo
• Livdelzi
• UDCA
• Xifaxan + lactulose

How to submit the appeal to Blue Cross NC

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross NC cited in the denial.
3. File the appeal through Blue Cross NC's portal (members: https://www.bluecrossnc.com ; providers: https://www.bluecrossnc.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In NC, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross NC's prior-authorization criteria by drug: Blue Cross NC PA criteria on ApprovalHelp.